Fine-tuning roles of endogenous brain-derived neurotrophic factor, TrkB and sortilin in colorectal cancer cell survival

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Akil, Hussein ^a,b   Perraud, Aurélie ^a,b,c   Mélin, Carole ^a,b   Jauberteau, Marie Odile ^a,b   Mathonnet, Muriel ^a,b,c  

^a UNIVERSITÉ DE LIMOGES   (France)

^b UNIVERSITY OF LIMOGES   (France)

^c LIMOGES UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; NEUROTROPHIN; NEUROTROPHIN RECEPTOR; NEUROTROPHIN RECEPTOR P75; SORTILIN; CARBAZOLE DERIVATIVE; INDOLE ALKALOID; NERVE GROWTH FACTOR RECEPTOR; NEUROTROPHIN 3 RECEPTOR; STAUROSPORINE AGLYCONE; VESICULAR TRANSPORT ADAPTOR PROTEIN;

APOPTOSIS; ARTICLE; BINDING AFFINITY; CANCER CELL; CELL MEMBRANE; CELL PROLIFERATION; CELL SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; CYTOPLASM; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; PROTEIN SYNTHESIS; PROTEIN TRANSPORT; COLORECTAL TUMOR; DRUG ANTAGONISM; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; WESTERN BLOTTING;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; APOPTOSIS; BLOTTING, WESTERN; BRAIN-DERIVED NEUROTROPHIC FACTOR; CARBAZOLES; CELL LINE, TUMOR; CELL MEMBRANE; CELL PROLIFERATION; COLORECTAL NEOPLASMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; INDOLE ALKALOIDS; RECEPTOR, TRKB; RECEPTOR, TRKC; RECEPTORS, NERVE GROWTH FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 80053157959     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0025097     Document Type: Article

References (70)

1. Arevalo JC, Wu SH, (2006) Neurotrophin signaling: many exciting surprises! Cell Mol Life Sci 63: 1523-1537.
2. Seidah NG, Benjannet S, Pareek S, Chretien M, Murphy RA, (1996) Cellular processing of the neurotrophin precursors of NT3 and BDNF by the mammalian proprotein convertases. FEBS Lett 379: 247-250.
3. Rose CR, Blum R, Pichler B, Lepier A, Kafitz KW, et al. (2003) Truncated TrkB-T1 mediates neurotrophin-evoked calcium signalling in glia cells. Nature 426: 74-78.
4. Carim-Todd L, Bath KG, Fulgenzi G, Yanpallewar S, Jing D, et al. (2009) Endogenous truncated TrkB.T1 receptor regulates neuronal complexity and TrkB kinase receptor function in vivo. J Neurosci 29: 678-685.
5. Strohmaier C, Carter BD, Urfer R, Barde YA, Dechant G, (1996) A splice variant of the neurotrophin receptor trkB with increased specificity for brain-derived neurotrophic factor. EMBO J 15: 3332-3337.
6. Chao MV, (2003) Neurotrophins and their receptors: a convergence point for many signalling pathways. Nat Rev Neurosci 4: 299-309.
7. Frade JM, Rodriguez-Tebar A, Barde YA, (1996) Induction of cell death by endogenous nerve growth factor through its p75 receptor. Nature 383: 166-168.
8. Fauchais AL, Lalloue F, Lise MC, Boumediene A, Preud'homme JL, et al. (2008) Role of endogenous brain-derived neurotrophic factor and sortilin in B cell survival. J Immunol 181: 3027-3038.
9. Nykjaer A, Lee R, Teng KK, Jansen P, Madsen P, et al. (2004) Sortilin is essential for proNGF-induced neuronal cell death. Nature 427: 843-848.
10. Teng HK, Teng KK, Lee R, Wright S, Tevar S, et al. (2005) ProBDNF induces neuronal apoptosis via activation of a receptor complex of p75NTR and sortilin. J Neurosci 25: 5455-5463.
11. Dechant G, (2001) Molecular interactions between neurotrophin receptors. Cell Tissue Res 305: 229-238.
12. Lee R, Kermani P, Teng KK, Hempstead BL, (2001) Regulation of cell survival by secreted proneurotrophins. Science 294: 1945-1948.
13. Jansen P, Giehl K, Nyengaard JR, Teng K, Lioubinski O, et al. (2007) Roles for the pro-neurotrophin receptor sortilin in neuronal development, aging and brain injury. Nat Neurosci 10: 1449-1457.
14. Nielsen MS, Jacobsen C, Olivecrona G, Gliemann J, Petersen CM, (1999) Sortilin/neurotensin receptor-3 binds and mediates degradation of lipoprotein lipase. J Biol Chem 274: 8832-8836.
15. Chen ZY, Ieraci A, Teng H, Dall H, Meng CX, et al. (2005) Sortilin controls intracellular sorting of brain-derived neurotrophic factor to the regulated secretory pathway. J Neurosci 25: 6156-6166.
16. Vaegter CB, Jansen P, Fjorback AW, Glerup S, Skeldal S, et al. (2011) Sortilin associates with Trk receptors to enhance anterograde transport and neurotrophin signaling. Nat Neurosci 14: 54-61.
17. Mazella J, Zsurger N, Navarro V, Chabry J, Kaghad M, et al. (1998) The 100-kDa neurotensin receptor is gp95/sortilin, a non-G-protein-coupled receptor. J Biol Chem 273: 26273-26276.
18. Navarro V, Vincent JP, Mazella J, (2002) Shedding of the luminal domain of the neurotensin receptor-3/sortilin in the HT29 cell line. Biochem Biophys Res Commun 298: 760-764.
19. Nakamura K, Martin KC, Jackson JK, Beppu K, Woo CW, et al. (2006) Brain-derived neurotrophic factor activation of TrkB induces vascular endothelial growth factor expression via hypoxia-inducible factor-1alpha in neuroblastoma cells. Cancer Res 66: 4249-4255.
20. Schramm A, Schulte JH, Astrahantseff K, Apostolov O, Limpt V, et al. (2005) Biological effects of TrkA and TrkB receptor signaling in neuroblastoma. Cancer Lett 228: 143-153.
21. Tajima Y, Molina RP Jr, Rorke LB, Kaplan DR, Radeke M, et al. (1998) Neurotrophins and neuronal versus glial differentiation in medulloblastomas and other pediatric brain tumors. Acta Neuropathol 95: 325-332.
22. Bronzetti E, Artico M, Forte F, Pagliarella G, Felici LM, et al. (2008) A possible role of BDNF in prostate cancer detection. Oncol Rep 19: 969-974.
23. Montano X, Djamgoz MB, (2004) Epidermal growth factor, neurotrophins and the metastatic cascade in prostate cancer. FEBS Lett 571: 1-8.
24. Ricci A, Greco S, Mariotta S, Felici L, Bronzetti E, et al. (2001) Neurotrophins and neurotrophin receptors in human lung cancer. Am J Respir Cell Mol Biol 25: 439-446.
25. Ketterer K, Rao S, Friess H, Weiss J, Buchler MW, et al. (2003) Reverse transcription-PCR analysis of laser-captured cells points to potential paracrine and autocrine actions of neurotrophins in pancreatic cancer. Clin Cancer Res 9: 5127-5136.
26. Sclabas GM, Fujioka S, Schmidt C, Li Z, Frederick WA, et al. (2005) Overexpression of tropomysin-related kinase B in metastatic human pancreatic cancer cells. Clin Cancer Res 11: 440-449.
27. Wang W, Zhao H, Zhang S, Kang E, Chen Y, et al. (2009) Patterns of expression and function of the p75(NGFR) protein in pancreatic cancer cells and tumours. Eur J Surg Oncol 35: 826-832.
28. Yang ZF, Ho DW, Lam CT, Luk JM, Lum CT, et al. (2005) Identification of brain-derived neurotrophic factor as a novel functional protein in hepatocellular carcinoma. Cancer Res 65: 219-225.
29. Brunetto de Farias C, Rosemberg DB, Heinen TE, Koehler-Santos P, Abujamra AL, et al. (2010) BDNF/TrkB content and interaction with gastrin-releasing peptide receptor blockade in colorectal cancer. Oncology 79: 430-439.
30. Yu Y, Zhang S, Wang X, Yang Z, Ou G, (2010) Overexpression of TrkB promotes the progression of colon cancer. APMIS 118: 188-195.
31. Noguchi P, Wallace R, Johnson J, Earley EM, O'Brien S, et al. (1979) Characterization of the WIDR: a human colon carcinoma cell line. In Vitro 15: 401-408.
32. Leibovitz A, Stinson JC, McCombs 3rd WB, McCoy CE, Mazur KC, et al. (1976) Classification of human colorectal adenocarcinoma cell lines. Cancer Res 36: 4562-4569.
33. Semple TU, Quinn LA, Woods LK, Moore GE, (1978) Tumor and lymphoid cell lines from a patient with carcinoma of the colon for a cytotoxicity model. Cancer Res 38: 1345-1355.
34. Edge SB, Compton CC, (2010) The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 17: 1471-1474.
35. De Armas R, Durand K, Guillaudeau A, Weinbreck N, Robert S, et al. (2010) mRNA levels of enzymes and receptors implicated in arachidonic acid metabolism in gliomas. Clin Biochem 43: 827-835.
36. Kaebisch A, Brokt S, Seay U, Lohmeyer J, Jaeger U, et al. (1996) Expression of the nerve growth factor receptor c-TRK in human myeloid leukaemia cells. Br J Haematol 95: 102-109.
37. Tapley P, Lamballe F, Barbacid M, (1992) K252a is a selective inhibitor of the tyrosine protein kinase activity of the trk family of oncogenes and neurotrophin receptors. Oncogene 7: 371-381.
38. Streppel M, Azzolin N, Dohm S, Guntinas-Lichius O, Haas C, et al. (2002) Focal application of neutralizing antibodies to soluble neurotrophic factors reduces collateral axonal branching after peripheral nerve lesion. Eur J Neurosci 15: 1327-1342.
39. Matsumoto K, Wada RK, Yamashiro JM, Kaplan DR, Thiele CJ, (1995) Expression of brain-derived neurotrophic factor and p145TrkB affects survival, differentiation, and invasiveness of human neuroblastoma cells. Cancer Res 55: 1798-1806.
40. Nakagawara A, Azar CG, Scavarda NJ, Brodeur GM, (1994) Expression and function of TRK-B and BDNF in human neuroblastomas. Mol Cell Biol 14: 759-767.
41. Pearse RN, Swendeman SL, Li Y, Rafii D, Hempstead BL, (2005) A neurotrophin axis in myeloma: TrkB and BDNF promote tumor-cell survival. Blood 105: 4429-4436.
42. Lai PC, Chiu TH, Huang YT, (2010) Overexpression of BDNF and TrkB in human bladder cancer specimens. Oncol Rep 24: 1265-1270.
43. Kawamura N, Kawamura K, Manabe M, Tanaka T, (2010) Inhibition of brain-derived neurotrophic factor/tyrosine kinase B signaling suppresses choriocarcinoma cell growth. Endocrinology 151: 3006-3014.
44. Aoyama M, Asai K, Shishikura T, Kawamoto T, Miyachi T, et al. (2001) Human neuroblastomas with unfavorable biologies express high levels of brain-derived neurotrophic factor mRNA and a variety of its variants. Cancer Lett 164: 51-60.
45. Au CW, Siu MK, Liao X, Wong ES, Ngan HY, et al. (2009) Tyrosine kinase B receptor and BDNF expression in ovarian cancers- Effect on cell migration, angiogenesis and clinical outcome. Cancer Lett 281: 151-161.
46. Kupferman ME, Jiffar T, El-Naggar A, Yilmaz T, Zhou G, et al. (2010) TrkB induces EMT and has a key role in invasion of head and neck squamous cell carcinoma. Oncogene 29: 2047-2059.
47. Terry J, De Luca A, Leung S, Peacock G, Wang Y, et al. (2011) Immunohistochemical expression of neurotrophic tyrosine kinase receptors 1 and 2 in lung carcinoma: potential discriminators between squamous and nonsquamous subtypes. Arch Pathol Lab Med 135: 433-439.
48. Lam CT, Yang ZF, Lau CK, Tam KH, Fan ST, et al. (2011) Brain-Derived Neurotrophic Factor Promotes Tumorigenesis via Induction of Neovascularization: Implication in Hepatocellular Carcinoma. Clin Cancer Res 17: 3123-3133.
49. Li Z, Chang Z, Chiao LJ, Kang Y, Xia Q, et al. (2009) TrkBT1 induces liver metastasis of pancreatic cancer cells by sequestering Rho GDP dissociation inhibitor and promoting RhoA activation. Cancer Res 69: 7851-7859.
50. Thiele CJ, Li Z, McKee AE, (2009) On Trk-the TrkB signal transduction pathway is an increasingly important target in cancer biology. Clin Cancer Res 15: 5962-5967.
51. Smit MA, Geiger TR, Song JY, Gitelman I, Peeper DS, (2009) A Twist-Snail axis critical for TrkB-induced epithelial-mesenchymal transition-like transformation, anoikis resistance, and metastasis. Mol Cell Biol 29: 3722-3737.
52. Smit MA, Peeper DS, (2011) Zeb1 is required for TrkB-induced epithelial-mesenchymal transition, anoikis resistance and metastasis. Oncogene.
53. Douma S, Van Laar T, Zevenhoven J, Meuwissen R, Van Garderen E, et al. (2004) Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB. Nature 430: 1034-1039.
54. Middlemas DS, Kihl BK, Moody NM, (1999) Brain derived neurotrophic factor protects human neuroblastoma cells from DNA damaging agents. J Neurooncol 45: 27-36.
55. Middlemas DS, Kihl BK, Zhou J, Zhu X, (1999) Brain-derived neurotrophic factor promotes survival and chemoprotection of human neuroblastoma cells. J Biol Chem 274: 16451-16460.
56. Hu Y, Sun CY, Wang HF, Guo T, Wei WN, et al. (2006) Brain-derived neurotrophic factor promotes growth and migration of multiple myeloma cells. Cancer Genet Cytogenet 169: 12-20.
57. Hu Y, Wang YD, Guo T, Wei WN, Sun CY, et al. (2007) Identification of brain-derived neurotrophic factor as a novel angiogenic protein in multiple myeloma. Cancer Genet Cytogenet 178: 1-10.
58. D'Onofrio M, de Grazia U, Morrone S, Cuomo L, Spinsanti P, et al. (2000) Expression of neurotrophin receptors in normal and malignant B lymphocytes. Eur Cytokine Netw 11: 283-291.
59. Feng X, Jiang H, Baik JC, Edgar C, Eide FF, (2001) BDNF dependence in neuroblastoma. J Neurosci Res 64: 355-363.
60. Jaboin J, Kim CJ, Kaplan DR, Thiele CJ, (2002) Brain-derived neurotrophic factor activation of TrkB protects neuroblastoma cells from chemotherapy-induced apoptosis via phosphatidylinositol 3′-kinase pathway. Cancer Res 62: 6756-6763.
61. Cheng A, Wang S, Yang D, Xiao R, Mattson MP, (2003) Calmodulin mediates brain-derived neurotrophic factor cell survival signaling upstream of Akt kinase in embryonic neocortical neurons. J Biol Chem 278: 7591-7599.
62. Cheng A, Wang S, Cai J, Rao MS, Mattson MP, (2003) Nitric oxide acts in a positive feedback loop with BDNF to regulate neural progenitor cell proliferation and differentiation in the mammalian brain. Dev Biol 258: 319-333.
63. Qiu L, Zhou C, Sun Y, Di W, Scheffler E, et al. (2006) Crosstalk between EGFR and TrkB enhances ovarian cancer cell migration and proliferation. Int J Oncol 29: 1003-1011.
64. Islekel H, Oktay G, Terzi C, Canda AE, Fuzun M, et al. (2007) Matrix metalloproteinase-9,-3 and tissue inhibitor of matrix metalloproteinase-1 in colorectal cancer: relationship to clinicopathological variables. Cell Biochem Funct 25: 433-441.
65. Nielsen MS, Madsen P, Christensen EI, Nykjaer A, Gliemann J, et al. (2001) The sortilin cytoplasmic tail conveys Golgi-endosome transport and binds the VHS domain of the GGA2 sorting protein. EMBO J 20: 2180-2190.
66. Westergaard UB, Sorensen ES, Hermey G, Nielsen MS, Nykjaer A, et al. (2004) Functional organization of the sortilin Vps10p domain. J Biol Chem 279: 50221-50229.
67. Beattie MS, Harrington AW, Lee R, Kim JY, Boyce SL, et al. (2002) ProNGF induces p75-mediated death of oligodendrocytes following spinal cord injury. Neuron 36: 375-386.
68. Hempstead BL, (2002) The many faces of p75NTR. Curr Opin Neurobiol 12: 260-267.
69. Dimaras H, Coburn B, Pajovic S, Gallie BL, (2006) Loss of p75 neurotrophin receptor expression accompanies malignant progression to human and murine retinoblastoma. Mol Carcinog 45: 333-343.
70. Schulte JH, Pentek F, Hartmann W, Schramm A, Friedrichs N, et al. (2009) The low-affinity neurotrophin receptor, p75, is upregulated in ganglioneuroblastoma/ganglioneuroma and reduces tumorigenicity of neuroblastoma cells in vivo. Int J Cancer 124: 2488-2494.